Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)

BACKGROUND: Induction chemotherapy (ICT) with docetaxel, cisplatin and fluorouracil (TPF) followed by radiotherapy is an effective treatment option for unresectable locally advanced head and neck cancer. This phase I study was designed to investigate the safety and tolerability of a split-dose TPF I...

Descripción completa

Detalles Bibliográficos
Autores principales: Oertel, Katrin, Spiegel, Karin, Schmalenberg, Harald, Dietz, Andreas, Maschmeyer, Georg, Kuhnt, Thomas, Sudhoff, Holger, Wendt, Thomas G, Guntinas-Lichius, Orlando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485626/
https://www.ncbi.nlm.nih.gov/pubmed/23083061
http://dx.doi.org/10.1186/1471-2407-12-483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485626/
https://www.ncbi.nlm.nih.gov/pubmed/23083061
http://dx.doi.org/10.1186/1471-2407-12-483

Ejemplares similares